https://www.taxtmi.com/notifications?id=137794 Exempts specified medicinal products used for COVID-19 from a portion of State GST by prescribing reduced rates for listed Chapter 30 tariff items at either Nil or 2.5 percent. The notification lists Tocilizumab and Amphotericin B at Nil rate and several antiviral, biologic and adjunct therapies at 2.5 percent. The exemption is effective from 1 October 2021 through 31 December 2021 as a time limited State tax relief. en-us Thu, 30 Sep 2021 00:00:00 +0530 Sat, 05 Mar 2022 18:01:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/notifications?id=137794 Exempts specified medicinal products used for COVID-19 from a portion of State GST by prescribing reduced rates for listed Chapter 30 tariff items at either Nil or 2.5 percent. The notification lists Tocilizumab and Amphotericin B at Nil rate and several antiviral, biologic and adjunct therapies at 2.5 percent. The exemption is effective from 1 October 2021 through 31 December 2021 as a time limited State tax relief. Notifications GST - States Thu, 30 Sep 2021 00:00:00 +0530 https://www.taxtmi.com/notifications?id=137794